ASH 2020: Dr. Bill Wierda on CAR-T liso-cel combined with ibrutinib for chronic lymphocytic leukemia (CLL)
Many CLL experts believe that Dr. Wierda’s exciting oral presentation on the success of combining the CAR-T liso-cel with ibrutinib could be the harbinger of a new era in how we will treat CLL in the near future.